Literature DB >> 25314249

Association of markers of hemostasis with death in HIV-infected women.

Elizabeth Kiefer1, Donald R Hoover, Qiuhu Shi, Mark H Kuniholm, Michael Augenbraun, Mardge H Cohen, Elizabeth T Golub, Robert C Kaplan, Chenglong Liu, Marek Nowicki, Phyllis C Tien, Russell P Tracy, Kathryn Anastos.   

Abstract

: In HIV negatives, markers of hemostasis, including D-dimer, factor VIII, plasminogen activator inhibitor-1 antigen (PAI-1), and total protein S are associated with all-cause and cardiovascular disease mortality. In HIV positives, studies of D-dimer and factor VIII with death were limited to short follow-up; associations of PAI-1 and total protein S with death have not been examined. In 674 HIV-infected women from the Women's Interagency HIV Study, markers from the first visit after enrollment were exposures of interest in multivariate analyses of death (AIDS and non-AIDS) in separate models at 5 and 16 years. There were 87 AIDS and 44 non-AIDS deaths at 5 years, and 159 AIDS and 113 non-AIDS deaths at 16 years. An inverse association of total protein S quartiles with non-AIDS deaths was observed at 5 (P trend = 0.002) and 16 years (P trend = 0.02); there was no association with AIDS deaths. The third quartile of PAI-1 was associated with AIDS deaths at 5 [hazard ratio (HR) = 4.0; 95% confidence interval (CI): 1.9 to 8.4] and 16 years (HR = 3.4; 95% CI: 1.9 to 5.9); and with non-AIDS deaths at 5 years (HR = 4.8; 95% CI: 1.6 to 13.9). D-dimer and factor VIII were not associated with AIDS or non-AIDS death at 5 or 16 years. Lower total Protein S was a consistent marker of non-AIDS death. We found no association between D-dimer with AIDS or non-AIDS death, in contrast to previous studies showing increased short-term (<5 years) mortality, which may represent sex differences or population heterogeneity. Given longer survival on highly active antiretroviral therapy, further studies of these markers are needed to determine their prognostic value.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314249      PMCID: PMC4197808          DOI: 10.1097/QAI.0000000000000306

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  50 in total

1.  Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D Lowe
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

2.  Protein S deficiency and HIV infection.

Authors:  A Lafeuillade; M C Alessi; I Poizot-Martin; C Dhiver; R Quilichini; L Aubert; J A Gastaut; I Juhan-Vague
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

3.  Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure.

Authors:  Ali Zorlu; Mehmet Birhan Yilmaz; Hasan Yucel; Gokhan Bektasoglu; Meltem Refiker Ege; Izzet Tandogan
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

4.  Racial and gender differences in the incidence of recurrent venous thromboembolism.

Authors:  Richard H White; William E Dager; Hong Zhou; Susan Murin
Journal:  Thromb Haemost       Date:  2006-09       Impact factor: 5.249

5.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.

Authors:  M Cushman; R N Lemaitre; L H Kuller; B M Psaty; E M Macy; A R Sharrett; R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

6.  Early mortality and cause of deaths in patients using HAART in Brazil and the United States.

Authors:  Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

Review 7.  A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.

Authors:  M H Prins; J Hirsh
Journal:  Arch Intern Med       Date:  1991-09

Review 8.  Fibrinolysis: the key to new pathogenetic mechanisms.

Authors:  Esther Zorio; Juan Gilabert-Estellés; Francisco España; Luis A Ramón; Raul Cosín; Amparo Estellés
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Fibrin fragment D-dimer and the risk of future venous thrombosis.

Authors:  Mary Cushman; Aaron R Folsom; Lu Wang; Nena Aleksic; Wayne D Rosamond; Russell P Tracy; Susan R Heckbert
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Thrombotic tendencies and correlation with clinical status in patients infected with HIV.

Authors:  S E Feffer; R L Fox; M M Orsen; K J Harjai; A E Glatt
Journal:  South Med J       Date:  1995-11       Impact factor: 0.954

View more
  2 in total

1.  Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.

Authors:  Jessica L Montoya; Jennifer Iudicello; Hannah A Oppenheim; Pariya L Fazeli; Michael Potter; Qing Ma; Paul J Mills; Ronald J Ellis; Igor Grant; Scott L Letendre; David J Moore
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

2.  Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Authors:  Masresha Seyoum; Bamlaku Enawgaw; Zegeye Getaneh; Getabalew Engidaye; Fikir Asrie; Mulugeta Melku
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.